Literature DB >> 7042733

Role of the sympathetic nervous system in blood pressure maintenance in obesity.

J R Sowers, L A Whitfield, R A Catania, N Stern, M L Tuck, L Dornfeld, M Maxwell.   

Abstract

A group of 10 borderline hypertensive obese subjects had higher (P less than 0.05) supine plasma norepinephrine (NE), epinephrine, and PRA levels as well as greater (P less than 0.05) NE responses to upright posture and isometric handgrip exercise than 12 nonobese controls. Plasma NE as well as mean arterial pressure (MAP) responses to posture and handgrip in the obese patients demonstrated a significant decrement at week 2 after the onset of a low calorie diet. Decrements in plasma NE and MAP responses to posture were correlated (r = 0.61; P less than 0.05) throughout an 8-week period of weight loss in these borderline hypertensive obese subjects. In 15 normotensive obese subjects as well as in the 10 borderline hypertensive obese subjects, weight reduction associated with a very low calorie intake was accompanied by a reduction in supine plasma NE, epinephrine, and MAP 2 weeks after the onset of dieting. PRA decreased after 8 weeks of dieting in both obese groups, and these PRA decrements were correlated with reductions in MAP and decrements in plasma NE. We conclude that enhanced sympathetic activity may play a role in the maintenance of elevated blood pressure in obese individuals. Decreases in PRA and blood pressure associated with weight loss in both normotensive and hypertensive obese individuals occurs, in part, secondary to reductions in plasma NE levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042733     DOI: 10.1210/jcem-54-6-1181

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Cardiovascular risks in obesity.

Authors:  E C Uchegbu; P G Kopelman
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

Authors:  C Berne; J Fagius; T Pollare; P Hjemdahl
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

4.  Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings.

Authors:  C Berne; J Fagius; F Niklasson
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

Review 5.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 6.  Insulin resistance and hypertension--implications for treatment.

Authors:  P A Rutherford; T H Thomas; R Wilkinson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

7.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

Review 8.  Cardiovascular and sympathetic effects of leptin.

Authors:  Kamal Rahmouni; William G Haynes; Allyn L Mark
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

9.  Obesity as a determinant for response to antihypertensive treatment.

Authors:  R E Schmieder; C Gatzka; H Schächinger; H Schobel; H Rüddel
Journal:  BMJ       Date:  1993-08-28

10.  Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells.

Authors:  F Saito; M T Hori; M Fittingoff; T Hino; M L Tuck
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.